MedTrace Logo

Therapeutic Exposures and Risk Factors in MRONJ

NCT06430762 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-05-28

No results posted yet for this study

Summary

This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.

Conditions

  • Medication-Related Osteonecrosis of Jaw

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Ferit Bayram, PhD · Marmara University Faculty of Dentistry

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-25
Primary Completion
2026-04-25
Completion
2027-04-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06430762 on ClinicalTrials.gov